Almirall, S.A. Nominates Carlos Gallardo as Vice President of the Board of Directors Effective November 9, 2020
November 09, 2020 at 01:45 am EST
Share
Almirall, S.A. has announced the nomination of Carlos Gallardo as Vice President of the Board of Directors effective November 9, 2020 Carlos has been increasingly involved in several key committees within the company, including the Pipeline Committee and the Digital Steering Committee, which he chairs. This deep immersion has prepared him for his new expanded responsibilities. Carlos has broad international healthcare experience. He started his pharmaceutical career in Pfizer prior to joining the company where he held positions of increasing seniority over nearly 10 years. Since leaving the company as General Manager of the UK and Ireland in 2013, Carlos has served as a member of company's Board of Directors. In addition, he has established a successful career as a venture capitalist investing in digital health. He is the founder and CEO of CG Health Ventures where he invests in and builds digital health companies that match technology and talent to solve for challenges in healthcare. He serves on a number of boards of promising early stage digital health and health technology startups.
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
ALMIRALL, S.A. 
